Oncolytic virus

From WikiMD's Medical Encyclopedia

Revision as of 21:10, 24 February 2024 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Oncolytic virus is a type of virus that specifically infects and kills cancer cells. Oncolytic viruses are thought to work by selectively replicating in and killing cancer cells, thereby releasing a progeny virus that can infect other similar cells. This is in contrast to traditional therapies, such as chemotherapy and radiation therapy, which destroy both cancerous and healthy cells.

History

The concept of oncolytic viruses dates back to the 19th century, when doctors noticed that some cancer patients experienced remission after suffering from viral infections. However, it wasn't until the late 20th century that scientists began to understand the mechanisms by which viruses could be used to target cancer cells.

Mechanism of Action

Oncolytic viruses are able to selectively infect and kill cancer cells due to differences in the cellular machinery of normal and cancerous cells. These differences allow the virus to replicate in cancer cells, but not in normal cells. Once the virus has replicated, it causes the cancer cell to burst, releasing the new viruses to infect other cancer cells.

Types of Oncolytic Viruses

There are several types of oncolytic viruses currently being researched, including adenoviruses, herpes simplex viruses, and vesicular stomatitis viruses. Each of these viruses has unique properties that make them suitable for targeting certain types of cancer.

Clinical Trials

Several oncolytic viruses are currently in clinical trials for the treatment of various types of cancer. These trials are designed to test the safety and efficacy of the viruses, as well as to determine the optimal dosage and delivery method.

Future Directions

Research into oncolytic viruses is ongoing, with scientists continually discovering new ways to enhance the selectivity and potency of these viruses. Future directions for this field include the development of combination therapies, in which oncolytic viruses are used in conjunction with other treatments, such as chemotherapy or radiation therapy.

See Also

References

<references />

This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia


Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.